ALVOGYL 25.7 G / 100 G
BUTAMBEN : 25.7 G / 100 G IODOFORM : 15.8 G / 100 G PENGHAWAR : 3.5 G / 100 G EUGENOL : 13.7 G / 100 G · DIN 00555509 · SEPTODONT
Health Canada status: CANCELLED POST MARKET
What is ALVOGYL?
ALVOGYL 25.7 G / 100 G contains BUTAMBEN : 25.7 G / 100 G IODOFORM : 15.8 G / 100 G PENGHAWAR : 3.5 G / 100 G EUGENOL : 13.7 G / 100 G. It is listed in the Health Canada Drug Product Database under DIN 00555509, held by SEPTODONT, supplied as PASTE for DENTAL administration. Health Canada currently lists it as cancelled post market, status dated 02-Aug-2013. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00555509 |
|---|---|
| Brand name | ALVOGYL |
| Generic / active ingredient | BUTAMBEN : 25.7 G / 100 G IODOFORM : 15.8 G / 100 G PENGHAWAR : 3.5 G / 100 G EUGENOL : 13.7 G / 100 G |
| Manufacturer | SEPTODONT |
| Strength | 25.7 G / 100 G |
| Dosage form | PASTE |
| Route of administration | DENTAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A01AD11 VARIOUS |
| AHFS class | 34:00.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 02-Aug-2013 |
| Original market date | 1973-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A01AD11 VARIOUS. 1 of 73 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| XYLONOR GEL | 150 MG / 100 G | GEL | SEPTODONT | MARKETED | DIN 00479896 |
| ALUM POWDERED | POWDER | DAWSON TRADERS LTD. | CANCELLED POST MARKET | DIN 00328049 | |
| ALUM PWR | POWDER | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | CANCELLED POST MARKET | DIN 00179159 | |
| AMBER MOUTH WASH - LIQ | 0.092 % | LIQUID | PERRIGO INTERNATIONAL | CANCELLED POST MARKET | DIN 02212595 |
| AMBER MOUTHWASH - LIQ | 0.042 % | LIQUID | PERRIGO INTERNATIONAL | CANCELLED POST MARKET | DIN 02220695 |
| ANBESOL BABY GEL 7.5% | 7.5 % | GEL | WYETH CONSUMER HEALTHCARE INC. | CANCELLED POST MARKET | DIN 01931040 |
| ANBESOL EXTRA STRENGTH GEL - 20% | 20 % | GEL | WHITEHALL-ROBINS INC. | CANCELLED POST MARKET | DIN 02127490 |
| ANBESOL GEL | 6.4 % | GEL | WYETH CONSUMER HEALTHCARE INC. | CANCELLED POST MARKET | DIN 01929453 |
| ANBESOL LIQUID | 0.25 % | LIQUID | WYETH CONSUMER HEALTHCARE INC. | CANCELLED POST MARKET | DIN 01929445 |
| ANBESOL MAXIMUM STRENGTH LIQUID | 20.0 % | LIQUID | WYETH CONSUMER HEALTHCARE INC. | CANCELLED POST MARKET | DIN 01932675 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.